ask="N/A"
ask_size="N/A"
average_daily_volume="421595"
bid="8.15"
bid_size="500"
book_value="3.69"
change="-0.65"
change_from_200_day_moving_average="-1.07"
change_from_50_day_moving_average="1.59"
change_from_52_week_high="-5.10"
change_From_52_week_low="5.44"
change_in_percent="-6.40%"
close="9.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.51"
eps_estimate_next_year="-1.95"
ex_dividend_date="N/A"
float_shares="15741000"
high="9.85"
high_52_weeks="14.60"
last_trade_date="3/17/2017"
last_trade_price="9.50"
last_trade_size="75039"
last_trade_time="4:00pm"
low="8.31"
low_52_weeks="4.06"
market_capitalization="169.54M"
moving_average_200_day="10.57"
moving_average_50_day="7.91"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="8.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.16%"
percent_change_from_50_day_moving_average="+20.08%"
percent_change_from_52_week_high="-34.93%"
percent_change_from_52_week_low="+134.05%"
previous_close="10.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.75"
price_per_sales="191.15"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.67"
stock_exchange="NCM"
symbol="STML"
volume="1164292"
weeks_range_52="4.06 - 14.60"
